Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Tuberculosis infection prevention by quick testing

28.09.2005


With a new DNA test, tuberculosis infection can be revealed so quickly that a patient doesn’t have time to infect others. This can be an important key to effective control of the disease.



The Norwegian biotechnology firm Genpoint is running trials, along with others financed by the Norwegian Research Council’s biotechnology program, of new and effective DNA tests at Ullevål University Hospital, the country’s national laboratory for tuberculosis.

Norwegian health officials calculate that a person infected with tuberculosis, with today’s diagnosis methods, can infect on average 20 others before the disease is detected and the patient can be isolated and treated.


The current manual test methods take at least a week, and the bacteria must incubate for up to eight weeks before an precise diagnosis can be made. This is a comprehensive process for both the patient and the laboratories that perform the tests. In addition, the tests must often be taken several times over a period of up to six months before it is certain what type of tuberculosis bacteria is being dealt with.

Genpoint’s automated DNA method simplifies diagnostics and provides test results that are available in a few minutes at best and in a few hours at worst. Therefore health personnel are able to test much larger groups, gaining much better and more effective control of the disease and its transmission.

The test methods are approved in the sense that Genpoint is in the process of fulfilling the requirements for documentation that have been set by the hospital laboratory in close co-operation with experts in the hospital milieu.

-We expect to be finished with the documentation period late this autumn and that the tests in the best case can be available for ordinary use in the country’s laboratories from late autumn or early next year, explains Genpoint’s Administrative Director Geir Gogstad.

The new test methods will mean an enormous difference from the existing test when it comes to the authorities’ ability to treat tuberculosis patients.

-Many more can be tested using far less money than today, without an increase of personnel in the health care sector”, says Gogstad.

Magic spheres

Genpoint makes use of magic spheres to isolate bacteria and holds a world-wide patent for the process. The spheres pull bacteria to themselves, and then dissolve the bacteria so that the DNA is released and absorbed by the spheres. With further analysis of the DNA, the bacteria can be identified. Both the cells and the DNA are captured by the same sphere surface, making it much easier to automate the process.

Genpoint operates in the global market with its products. New forms of tuberculosis bacteria are constantly being discovered, or so called mycobacteria, which tuberculosis-related bacteria. Many of these are resistant to antibiotics. Therefore the job to find more effective and speedy methods to identify the disease and reduce infection are more important than ever before, even though the disease over the last 40 years has been held in check in northern Europe thanks to vaccination programmes.

In the next round, Genpoint plans to further develop its tests to include multi-resistant staphylococcus, which is a world-wide problem in hospitals, but has begun to manifest itself as a contagion outside of hospitals. In this case, a quick and reliable method for identifying the oganism and beginning treatment is even more crucial because the staphylococcus is very resistant to antibiotics.

Elisabeth Kirkeng Andersen | alfa
Further information:
http://www.genpoint.no

More articles from Life Sciences:

nachricht New catalyst controls activation of a carbon-hydrogen bond
21.11.2017 | Emory Health Sciences

nachricht The main switch
21.11.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nanoparticles help with malaria diagnosis – new rapid test in development

The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.

Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Previous evidence of water on mars now identified as grainflows

21.11.2017 | Physics and Astronomy

NASA's James Webb Space Telescope completes final cryogenic testing

21.11.2017 | Physics and Astronomy

New catalyst controls activation of a carbon-hydrogen bond

21.11.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>